PhD student, Vrije Universiteit Brussel, Belgium
Elke Wuyts is a dedicated biomedical scientist with a strong passion for clinical research, focusing on technologies and therapies that directly benefit patients. With a commendable academic record and practical experience, she is driven to advance the field of biomedical research and improve patient outcomes.
Profile
Scopus
Education 🎓
Elke earned her Master’s in Biomedical Research from Vrije Universiteit Brussel (2020-2022), graduating Magna Cum Laude. Prior to that, she completed her Bachelor’s in Biomedical Sciences at the same university (2017-2020), achieving Cum Laude. Her educational background is complemented by a secondary education in Sciences and Languages from KA Pitzemburg Mechelen (2011-2017).
Experience 💼
Currently, Elke balances her role as a biomedical scientist with her position as a hospitality worker at L’Olivier, where she has developed valuable skills in managing diverse responsibilities and taking ownership of various tasks. Her experience in both scientific and service sectors has shaped her adaptable and responsible approach to work.
Research Interest 🔍
Elke is particularly interested in clinical research that incorporates innovative technologies and therapies aimed at engaging patients in their treatment processes. Her work explores the intersection of medical science and patient-centered care, focusing on improving therapeutic outcomes through effective interventions.
Awards 🏆
Although specific awards have not been detailed, Elke’s academic excellence is evidenced by her Cum Laude and Magna Cum Laude honors, reflecting her commitment to high standards in her studies and research pursuits.
Publications Top Notes 📚
Elke has contributed to several peer-reviewed publications, showcasing her research efforts:
- Het gebruik van gelijkstroomstimulatie gecombineerd met bupropion voor de behandeling van een patiënt en diens partner met rookverslaving, Tijdschrift Verslaving & Herstel, 2024. (Cited by: 5)
- Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study, PloS One, 2024. (Cited by: 12)